3rd October 2018: Cancer care in the South of England took a significant step forward today with the opening of the Rutherford Cancer Centre Thames Valley.
21st August 2018: A new chapter in the provision of advanced cancer care in the North-East of England has started with the official opening of the Rutherford Cancer Centre North East.
8th August 2018: The provision of advanced cancer treatment in the South of England passed a key milestone today with the arrival of the first high energy proton beam therapy system in the region.
7th August 2018: The first patient to be treated with high energy proton beam therapy for breast cancer in the UK commenced treatment this week at the Rutherford Cancer Centre South Wales.
11th April 2018: Proton Partners International announced today it has treated the first patient in the UK with high energy proton beam therapy.
20th March 2018: Proton Partners International has been granted formal technical and regulatory approval from Healthcare Inspectorate Wales to begin treating patients with proton beam therapy at its Rutherford Cancer Centre in Wales.
12th March 2018: IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed three new contracts with Proton Partners International, to install three Proteus®ONE* compact proton therapy solutions across the UK.
7th March 2018: Wales has shown ‘outstanding’ vision in helping to develop innovative proton beam therapy services for cancer patients.
22nd February 2018: Proton Partners International and Ion Beam Applications (IBA) Group, the world’s leading developers of high energy proton beam therapy centres and systems, have officially completed testing on the UK’s first high energy proton beam machine, the Proteus®ONE.
The creation of the first proton beam therapy cancer treatment centre to be built in the United Arab Emirates took a significant step forward today, as work officially began on site.
The centre, which will be known as the Abu Dhabi Proton Centre (ADPC), will be part of the existing Gulf International Cancer Centre (GICC) in Abu Dhabi and will be situated on a site provided by SBK Holding LLC, the Holding Company of His Highness Sheikh Dr. Sultan Bin Khalifa Bin Zayed Al Nahyan, advisor to the President of the United Arab Emirates.
Proton beam therapy is a highly-targeted type of radiotherapy which can treat hard-to-reach cancers, such as spinal tumours, with a lower risk of damaging the surrounding tissue and causing side effects.
Mike Moran, chief executive officer of Proton Partners International, said: “Today marks an important phase in our plans to revolutionize cancer treatment in the UAE and with works officially started, our vision will soon be a reality.
“There is a growing need for proton beam therapy treatment around the world, as it has been shown to deliver significant results for patients. Its effectiveness at lowering side effects compared to traditional radiation treatment, is transforming the lives of many thousands of cancer patients.
“Currently, there are no centres which offer proton beam therapy in the Middle East, so we are proud that Proton Partners will be the first to be bringing it to the UAE.”
Professor Karol Sikora, chief medical officer of Proton Partners International, added: “Studies have shown that at least 10% of patients who receive traditional radiotherapy would be treated more effectively with protons.
“By offering a variety of cancer therapies, this centre will deliver a fully comprehensive level of cancer care, tailored to fit the different needs of each patient – something which is not available in the UAE at the moment.”
His Highness Sheikh Dr. Sultan Bin Khalifa Bin Zayed Al Nahyan, said: “As today marks an important phase in our plans to revolutionize cancer treatment in the UAE and Middle East Region, we aim to provide a world-class medical treatment for all cancer patients.
“Driven by patient-friendly technology, high-quality medical facilities and proven results we give patients hope again.
“This will add to the numerous advantages the UAE has that makes it a prime destination for medical tourists.”